You may be eligible if you are:

  • A resident of the United States
  • A pregnant woman diagnosed with moderate-to-severe atopic dermatitis who has:
    • Taken CIBINQO (abrocitinib) during pregnancy or just prior to pregnancy (within 1 day prior to conception) or
    • Taken other medications for the treatment of moderate-to-severe atopic dermatitis during pregnancy or just prior to pregnancy or
    • Not taken any medications for the treatment of moderate-to-severe atopic dermatitis during pregnancy

Contact request form

I authorize the CIBINQO Pregnancy Registry to contact me and/or leave a message for me at these numbers or to contact me via email at the address listed below. I agree to the Registry referencing the CIBINQO Pregnancy Registry in messages or emails.

* marks required field.

The registry is open from 8:30 am – 5:00 pm EST Monday-Friday

Privacy Statement:

Pharmaceutical Product Development, LLC. (PPD) respects your privacy and understands that it is important to you. The information you provide on this form will be used to contact you for the purposes of assessing your eligibility to participate in the CIBINQO Pregnancy Registry. This information will be held by PPD and not shared with the study sponsor (Pfizer, Inc.) or any other third party without your permission. In the event you choose not to enroll, Registry staff will request permission to share your contact information with Pfizer, Inc. In order for them to contact you for safety follow up about your pregnancy. If you do not provide permission, and do not enroll in the Registry your contact details will be deleted.